Home Health Care News May 26, 2023
Amedisys Inc. (Nasdaq: AMED) is expected to merge with Option Care Health (Nasdaq: OPCH) in the back half of 2023. The deal, which valued the former at $3.6 billion, was announced at the beginning of May.
The shareholders of each company still have to approve the deal.
In the meantime, the two companies released a bevy of supportive analyst notes from a wide array of organizations. The document, dubbed “support for the merger,” was posted to the companies’ shared website.
“We see the long-term value of gaining more scale with payers and referral sources,” Bank of America (NYSE: BAC) wrote in its analysis. “Given the scale, we believe the combined businesses could grow faster than each company separately as they...
Today's Sponsors
Today's Sponsor